New long-term safety and efficacy data of investigational roflumilast cream 0.15% in mild to moderate atopic dermatitis will be presented in an ...
The positive top-line data from the Phase 2 study in treating alopecia areata (AA), an autoimmune condition resulting in hair loss, significantly influenced his perspective. Notably, the study ...
After opening up about living with alopecia during the second season of Bravo’s “Summer House: Martha’s Vineyard,” Jordan ...
“I have made it my mission to alleviate the suffering of patients with eczema and sensitive skin diseases, as well as other ...
Equillium (EQ) stock slips after the company posted initial data from a Phase 2 trial for EQ101, a cytokine inhibitor targeting alopecia areata. Read more here.
By Chris Wack Equillium said it saw positive topline data from its Phase 2, proof-of-concept study of EQ101 in adult patients with moderate, severe ...
Equillium says placebo rates in this indication across studies have been consistently low. Alopecia is an autoimmune disease that attacks the body’s hair follicles, causing patchy hair loss. The ...
Investigators found that the use of oral contraceptives (OCs) may be associated with an increased risk for frontal fibrosing ...